Pre-Stroke Modified Rankin Score (mRS) (v2020A2)

Specifications Manual for Joint Commission National Quality Measures (v2020A2)

Posted: 10/30/2019

Print this page

Home » Pre-Stroke Modified Rankin Score (mRS)

Release Notes:
Data Element
Version 2020A2

Name:

Pre-Stroke Modified Rankin Score (mRS)

Collected For:

CSTK-10

Definition:

The pre-stroke Modified Rankin Score (mRS) is an estimated score used to assess the patient’s pre-stroke level of function. An estimated mRS should be abstracted from current medical record documentation about the patient’s ability to perform activities of daily living prior to the hospitalization for the acute ischemic stroke event.

Question:

What is the patient's pre-stroke Modified Rankin Score (mRS)?

Format:

Length:	1
Type:	Alphanumeric
Occurs:	1

Allowable Values:

0 The patient had no residual symptoms.

1 The patient had no significant disability; able to carry out all activities.

2 The patient had slight disability; unable to carry out all activities but able to look after self without daily help.

3 The patient had moderate disability; requiring some external help but able to walk without the assistance of another individual.

4 The patient had moderately severe disability; unable to walk or attend to bodily functions without assistance of another individual.

5 The patient had severe disability; bedridden, incontinent, requires continuous care.

6 Unable to determine (UTD) from the medical record documentation.

Notes for Abstraction:

Use all available documentation in the current medical record to estimate a score and select a pre-stroke mRS value. mRS values documented during previous episodes of care may not be valid. Use only current data/information.
Documentation about the patient’s family and living situation may reflect the patient’s level of function prior to the hospital admission.
If documentation reflects that the patient was able to ambulate independently (no help form another person) with or without an assistive device, select value ‘0’, ‘1’, ‘2’, or ‘3’ based on the patient's level of disability.
If the patient was able to walk with the assistance of another person, select value ‘4’.
If the patient was unable to ambulate prior to the hospitalization, select value ‘5’.
Select the value (values 0-5) that best represents the patient’s pre-stroke level of function.
No value should be selected more than once.
If more than one value is estimated, select the highest value.
If a score range is estimated, e.g. 2-3, select the higher value.
If a pre-stroke mRS cannot be determined (UTD) from current medical record documentation, select “6”.
If value 6 (UTD) is selected, no other values should be selected.

Suggested Data Sources:

Consultation notes
Emergency department record
History and physical
Progress notes
Discharge summary
Admission note

Additional Notes:

Guidelines for Abstraction:

Inclusion	Exclusion
None	None

Specifications Manual for Joint Commission National Quality Measures (v2020A2)
Discharges 01-01-20 (1Q20) through 6-30-20 (2Q20)

LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.